Zoom News : Jul 13, 2021, 02:13 PM
New Delhi: Sputnik V manufacturer in India Dr. Reddy's Laboratories on Monday issued a statement saying the nationwide rollout of the Russian vaccine in India has now reached 50 cities and towns in India."We will strengthen the commercial roll-out of Sputnik V in the coming weeks. Neither the ongoing soft commercial launch nor work towards its ramp-up in India have been put on hold," Dr. Reddy's Laboratories said.In a statement on the Sputnik V vaccine in India, Dr. Reddy's Laboratories said the Sputnik V vaccine was launched on a soft pilot basis in India on May 14 this year and its commercial roll-out will strengthen in the coming weeks."Starting initially in Hyderabad, today the soft launch roll-out of Sputnik V has scaled up speedily and reached cities and towns all over India - including but not limited to Hyderabad, Vizag, Bengaluru. Mumbai, Navi Mumbai, Kolkata, Delhi NCR, Chennai, Miryalaguda, Vijayawada. Baddi, Kolhapur, Kochi. Raipur, Chandigarh, Pune. Nagpur, Nashik, Coimbatore, Ranchi, Jaipur. Lucknow, Patna. Bhubaneshwar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot. Palakkad. Allahabad. Dimapur, Kohima, Indore, Bhopal, Surat. Cuttack, Dharwad, Ernakulam, Ratlam. Faridabad, Srinagar. Gandhinagar, Vadodara, Gulbarga, Madurai, Guntur. Kannur, Jabalpur, Jalandhar, Kanpur. Mysore," it said."Dr. Reddy's has partnered with major hospitals across the country for this purpose, all of whom have successfully administered Sputnik V in India, including ongoing commercial roll-outs to the public," it added.As per an official release, Sputnik V showed strong safety with no cases of hospitalisation and good tolerability among the elderly in the country. The study was conducted among people in San Marino who received one or two doses of Sputnik V from March 4 to April 8. The results of the study were published in EClinicalMedicine, an open-access clinical journal published by The Lancet.